Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-09-27
2005-09-27
Guzo, David (Department: 1636)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023500, C536S024100, C536S024300
Reexamination Certificate
active
06949637
ABSTRACT:
Methods and compositions for diagnosing and treating asthma are provided. The methods involve the discovery of a correlation between an eotaxin gene polymorphism and the ocurrence of asthma.
REFERENCES:
patent: 6403782 (2002-06-01), Luster et al.
Garcia-Zepeda et al. Genomic organization, complete sequence, and chromosomal location of the gene for human eotaxin (SCYA11), an eosinophil-specific CC chemokine. Genomics. May 1, 1997;41(3):471-6.
Bartels et al. Human dermal fibroblasts express eotaxin: molecular cloning, mRNA expression, and identification of eotaxin sequence variants. Biochem Biophys Res Commun. Aug. 23, 1996;225(3):1045-51.
Entrez Nucleotide Database Accession No. HSU46572 (published May 13, 1997).
Entrez Nucleotide Database Accession No. AA125790 (last updated Nov. 26, 1996).
U.S. Appl. No. 60/000,449.
Drazen Jeffrey M.
Lilly Craig M.
Luster Andrew D.
Brigham and Women's Hospital, Inc.
Guzo David
Sullivan Daniel M.
The General Hospital Corporation
Wolf Greenfield & Sacks P.C.
LandOfFree
Methods for diagnosis, prediction and treatment of asthma... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for diagnosis, prediction and treatment of asthma..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for diagnosis, prediction and treatment of asthma... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3385755